Biktarvy - Antiretroviral Therapy for FeLV & FIV

Biktarvy - Antiretroviral Therapy for FeLV & FIV

Price
Regular price $10900
Regular price Sale price $10900
Save $-109
/
Content
Shipping calculated at checkout.
  • In stock, ready to ship
  • Backordered, shipping soon
  • Worldwide Shipping
  • Fast Delivery
  • 14-Days Money Back Guarantee
  • Secure Checkout

Pairs well with

Veterinary-compounded Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) oral tablets specially formulated for feline use. An off-label, human-medication-based treatment increasingly used by specialists to manage Feline Leukaemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) in cats by suppressing viral replication and helping restore immune function.

Active Ingredients

Bictegravir 10 mg + Emtricitabine 40 mg + Tenofovir Alafenamide 5 mg per tablet (tiny, palatable, or crushable)
⭐ Key Benefits

Significantly reduces viral load in many FeLV and FIV-positive cats
Improves quality of life: better appetite, weight gain, reduced secondary infections
Can extend lifespan and turn some cats into healthy, non-progressive carriers
Once-daily dosing makes long-term management practical
💊 Usage & Dosage

Give whole, hide in treat, or compound into flavoured liquid/chew for easier dosing.

Average adult cat (4-5 kg): 1 tablet once daily
Exact dose calculated by weight and blood work - always under veterinary supervision
⚠️ Side Effects

Mild gastrointestinal upset (vomiting, diarrheas) - usually resolves in first weeks
Rare: kidney value changes (tenofovir component) - regular blood work required
Very rare: lactic acidosis or bone density concerns with long-term use
❗ Importance

Blood work (CBC, chemistry panel, viral load PCR) every 3-6 months recommended.
You may also like